All Stories

  1. Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia

    Article • Mycoses, January 2015, Wiley

    Professor Michael G Kiehl

  2. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

    Article • Annals of Hematology, April 2014, Springer Science + Business Media

    Professor Michael G Kiehl

  3. Aspergillus PCR-Based Investigation of Fresh Tissue and Effusion Samples in Patients with Suspected Invasive Aspergillosis Enhances Diagnostic Capabilities

    Article • Journal of Clinical Microbiology, October 2013, ASM Journals

    Professor Michael G Kiehl

  4. Tumorinduzierte Hyperkalzämie

    Article • Der Internist, August 2013, Springer Science + Business Media

    Professor Michael G Kiehl

  5. Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

    Article • The Lancet Oncology, October 2012, Elsevier

    Professor Michael G Kiehl

  6. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies

    Article • Journal of Antimicrobial Chemotherapy, June 2012, Oxford University Press (OUP)

    Professor Michael G Kiehl

  7. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples

    Article • European Journal Of Haematology, June 2012, Wiley

    Professor Michael G Kiehl

  8. Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Article • Annals of Hematology, May 2012, Springer Science + Business Media

    Professor Michael G Kiehl

  9. Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals

    Article • Mycoses, April 2012, Wiley

    Professor Michael G Kiehl

  10. Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

    Article • Journal of Clinical Oncology, August 2011, American Society of Clinical Oncology (ASCO)

    Professor Michael G Kiehl

  11. Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

    Article • Bone Marrow Transplantation, October 2010, Springer Science + Business Media

    Professor Michael G Kiehl

  12. Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation

    Article • Haematologica, October 2009, Ferrata Storti Foundation (Haematologica)

    Professor Michael G Kiehl, Christian Thiede

  13. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology

    Article • European Journal of Cancer, September 2009, Elsevier

    Professor Michael G Kiehl

  14. Pulmonale Komplikationen nach hämatopoetischer Stammzelltransplantation – eine Herausforderung für die Intensivpflege

    Article • intensiv, July 2008, Thieme Publishing Group

    Professor Michael G Kiehl

  15. Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole

    Article • International Journal of Hematology, February 2008, Springer Science + Business Media

    Professor Michael G Kiehl

  16. Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study

    Article • Blood Coagulation & Fibrinolysis, September 2007, Wolters Kluwer Health

    Professor Michael G Kiehl

  17. Differential Requirement for a Cellular Type-1 Immune Response in Tumor-Associated Versus Alloantigen-Targeted GvT Effects

    Article • Transplantation, February 2007, Wolters Kluwer Health

    Professor Michael G Kiehl

  18. Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors

    Article • Clinical Transplantation, January 2007, Wiley

    Professor Michael G Kiehl

  19. Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Article • Annals of Hematology, June 2006, Springer Science + Business Media

    Professor Michael G Kiehl

  20. Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Article • Annals of Hematology, April 2006, Springer Science + Business Media

    Professor Michael G Kiehl

  21. Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study

    Article • European Journal Of Haematology, January 2006, Wiley

    Professor Michael G Kiehl

  22. Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

    Article • British Journal of Haematology, June 2005, Wiley

    Professor Michael G Kiehl

  23. Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma

    Article • Biology of Blood and Marrow Transplantation, October 2004, Elsevier

    Professor Michael G Kiehl

  24. Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in Adult Patients With Acute Lymphoblastic Leukemia: No Difference in Related Compared With Unrelated Transplant in First Complete Remission

    Article • Journal of Clinical Oncology, July 2004, American Society of Clinical Oncology (ASCO)

    Professor Michael G Kiehl

  25. Risk-factors of melphalan/fludarabine dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma

    Article • Biology of Blood and Marrow Transplantation, February 2004, Elsevier

    Professor Michael G Kiehl

  26. Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation – a retrospective analysis

    Article • Bone Marrow Transplantation, December 2003, Springer Science + Business Media

    Professor Michael G Kiehl, Christian Thiede

  27. Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies

    Article • Annals of Hematology, October 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  28. ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)

    Article • Bone Marrow Transplantation, August 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  29. Synergistic growth inhibitory effects of interferon-α and lovastatin on bcr-abl positive leukemic cells

    Article • International Journal of Oncology, July 2003, Spandidos Publications

    Professor Michael G Kiehl

  30. Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients

    Article • Annals of Hematology, June 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  31. Sepsis in neutropenia

    Article • Annals of Hematology, June 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  32. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia

    Article • Annals of Hematology, June 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  33. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor

    Article • Bone Marrow Transplantation, June 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  34. 192Dose-reduced conditioning with fludarabine/melphalan followed by allogeneic stem cell transplantation for patients with advanced stage II/III multiple myeloma

    Article • Biology of Blood and Marrow Transplantation, February 2003, Elsevier

    Professor Michael G Kiehl

  35. 50 Outcomes of HLA identical siblings are comparable to unrelated hematopoietic stem cell transplantation (HSCT) in adults with acute myeloid leukemia

    Article • Biology of Blood and Marrow Transplantation, February 2003, Elsevier

    Professor Michael G Kiehl

  36. Erythropoietic recovery during treatment with Darbepoietin-alpha after impaired rHuEPO response to anemia in two patients with osteomyelofibrosis after peripheral blood stem cell transplantation

    Article • The Hematology Journal, January 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  37. Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage

    Article • European Journal of Gastroenterology & Hepatology, January 2003, Wolters Kluwer Health

    Professor Michael G Kiehl

  38. TBI-Based Reduced Intensity Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation (SCT) in Patients with High-Risk Hematologic Malignancies

    Article • January 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  39. Nonmyeloablative Conditioning Regimen in Patients with High Risk Acute Myeloid Leukemia: Unrelated and Sibling Allogeneic Hematopoietic Stem Cell Transplantation

    Article • January 2003, Springer Science + Business Media

    Professor Michael G Kiehl

  40. Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients

    Article • Transplantation Proceedings, November 2002, Elsevier

    Professor Michael G Kiehl

  41. Reduced intensity preparative regimens for allogeneic hematopoietic stem cell transplantation: a single center experience

    Article • Bone Marrow Transplantation, November 2002, Springer Science + Business Media

    Professor Michael G Kiehl

  42. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT)

    Article • British Journal of Haematology, August 2002, Wiley

    Professor Michael G Kiehl

  43. FACTOR XIII REPLACEMENT IN STEM CELL TRANSPLANT (SCT) RECIPIENTS WITH SEVERE GRAFT-VERSUS-HOST DISEASE OF THE BOWEL: REPORT OF AN INITIAL EXPERIENCE

    Article • Transplantation, October 2001, Wolters Kluwer Health

    Professor Michael G Kiehl

  44. Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis

    Article • British Journal of Haematology, October 2001, Wiley

    Professor Michael G Kiehl

  45. Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients

    Article • Blood, September 2001, American Society of Hematology

    Professor Michael G Kiehl

  46. New immunosuppressants in BMT/GVHD

    Article • Transplantation Proceedings, May 2001, Elsevier

    Professor Michael G Kiehl

  47. New therapeutic modalities in the treatment of graft-versus-host disease

    Article • Critical Reviews in Oncology/Hematology, May 2001, Elsevier

    Professor Michael G Kiehl

  48. Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

    Article • Transplantation Proceedings, May 2001, Elsevier

    Professor Michael G Kiehl

  49. Eosinophilia in bone marrow after hematopoetic stem cell transplantation: does it indicate the onset of acute graft-versus-host disease?

    Article • European Journal of Cancer, April 2001, Elsevier

    Professor Michael G Kiehl

  50. Allogeneic hematopoietic stem cell transplantation in patients with beta-thalassemia

    Article • European Journal of Cancer, April 2001, Elsevier

    Professor Michael G Kiehl

  51. Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

    Article • British Journal of Haematology, March 2001, Wiley

    Professor Michael G Kiehl

  52. Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT

    Article • Bone Marrow Transplantation, February 2001, Springer Science + Business Media

    Professor Michael G Kiehl

  53. 'Graft versus host�-Reaktion - Stellenwert neuer Immunsuppressiva

    Article • January 2001, Karger Publishers

    Professor Michael G Kiehl

  54. Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study

    Article • Bone Marrow Transplantation, January 2001, Springer Science + Business Media

    Professor Michael G Kiehl

  55. Toxoplasmosis, a Severe Complication in Allogeneic Hematopoietic Stem Cell Transplantation: Successful Treatment Strategies during a 5-Year Single-Center Experience

    Article • Clinical Infectious Diseases, January 2001, Oxford University Press (OUP)

    Professor Michael G Kiehl

  56. Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation

    Article • DMW - Deutsche Medizinische Wochenschrift, January 2001, Thieme Publishing Group

    Professor Michael G Kiehl

  57. Preface

    Article • Bone Marrow Transplantation, May 2000, Springer Science + Business Media

    Professor Michael G Kiehl

  58. New strategies in GVHD prophylaxis

    Article • Bone Marrow Transplantation, May 2000, Springer Science + Business Media

    Professor Michael G Kiehl

  59. New strategies in the treatment of graft-versus-host disease

    Article • Bone Marrow Transplantation, May 2000, Springer Science + Business Media

    Professor Michael G Kiehl

  60. A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study

    Article • Bone Marrow Transplantation, May 2000, Springer Science + Business Media

    Professor Michael G Kiehl

  61. Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients

    Article • Clinical Transplantation, April 2000, Wiley

    Professor Michael G Kiehl

  62. Mycophenolate mofetil in the prevention of rejection after kidney transplantation

    Article • Transplantation, April 2000, Wolters Kluwer Health

    Professor Michael G Kiehl

  63. Atypical Chronic Myeloid Leukaemia with Trisomy 21 Mosaicism as a Sole Chromosomal Abnormality

    Article • Leukemia & Lymphoma, January 2000, Taylor & Francis

    Professor Michael G Kiehl

  64. Mycophenolate Mofetil for the Treatment of Acute and Chronic GVHD in Bone Marrow Transplant Patients

    Article • January 2000, Springer Science + Business Media

    Professor Michael G Kiehl

  65. Treatment of documented deep fungal infections in patients with sibling or unrelated stem cell transplantation: a study comparing safety and efficacy of conventional amphotericin B to liposomal amphotericin B (ambisome®)

    Article • European Journal of Cancer, September 1999, Elsevier

    Professor Michael G Kiehl

  66. PLASMA LEVELS OF MYCOPHENOLIC ACID AFTER ORAL MYCOFENOLAT MOFETIL IN PATIENTS AT HIGH RISK FOR GRAFT VERSUS HOST DISEASE (GVHD) AFTER BONE MARROW TRANSPLANTATION

    Article • Therapeutic Drug Monitoring, August 1999, Wolters Kluwer Health

    Professor Michael G Kiehl

  67. MPA/MPAG LEVELS DURING IV MYCOPHENOLATE MOFETIL (CELLCEPT®) PROPHYLAXIS FOR ACUTE GVHD IN BMT/SCT RECIPIENTS.

    Article • Therapeutic Drug Monitoring, August 1999, Wolters Kluwer Health

    Professor Michael G Kiehl

  68. Tyrosine phosphorylation in peripheral T cells of kidney transplant recipients: analyses of baseline levels and response to T cell receptor stimulation.

    Article • International Journal of Molecular Medicine, August 1999, Spandidos Publications

    Professor Michael G Kiehl

  69. NON INVASIVE VENTILATORY SUPPORT (CPAP) IN BMT/PBSCT

    Article • Critical Care Medicine, January 1999, Wolters Kluwer Health

    Professor Michael G Kiehl

  70. Lovastatin induces p21WAF1/Cip1 in human vascular smooth muscle cells: influence on protein phosphorylation, cell cycle, induction of apoptosis, and growth inhibition.

    Article • International Journal of Molecular Medicine, January 1999, Spandidos Publications

    Professor Michael G Kiehl

  71. Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

    Article • Transplantation Proceedings, December 1998, Elsevier

    Professor Michael G Kiehl

  72. Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome

    Article • Critical Care Medicine, July 1998, Wolters Kluwer Health

    Professor Michael G Kiehl

  73. Effects of NG-Nitro-L-Arginine-Methyl-Ester on Cardiopulmonary Function and Biosynthesis of Cyclooxygenase Products

    Article • Critical Care Medicine, June 1998, Wolters Kluwer Health

    Professor Michael G Kiehl

  74. Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis.

    Article • International Journal of Oncology, March 1998, Spandidos Publications

    Professor Michael G Kiehl

  75. Alterations of Protein Tyrosine Phosphorylation in T Cells of Immunocompromised Patients

    Article • Scandinavian Journal of Immunology, February 1998, Wiley

    Professor Michael G Kiehl

  76. The Optimum Use of Intravenous Immunoglobulin for Prophylaxis of Opportunistic Infection in HIV-Infected Adults

    Article • BioDrugs, January 1998, Springer Science + Business Media

    Professor Michael G Kiehl

  77. INFLAMMATORY MEDIATORS IN BRONCHOALVEOLAR LAVAGE FLUID AND PLASMA IN LEUKOCYTOPENIC PATIENTS WITH SEPTIC SHOCK INDUCED ARDS

    Article • Critical Care Medicine, January 1998, Wolters Kluwer Health

    Professor Michael G Kiehl

  78. EFFICACY OF MECHANICAL VENTILATION FOR SEVERE RESPIRATORY FAILURE IN BONE MARROW TRANSPLANT PATIENTS

    Article • Critical Care Medicine, January 1998, Wolters Kluwer Health

    Professor Michael G Kiehl

  79. Inflammatory Mediators in BAL Fluid as Markers of Evolving Pneumonia in Leukocytopenic Patients

    Article • CHEST Journal, November 1997, Elsevier

    Professor Michael G Kiehl

  80. Reciprocal Changes in Circulating Interleukin‐6 and Its Soluble Receptor during Evolving Sepsis in Leukocytopenic Patients

    Article • The Journal of Infectious Diseases, September 1997, Oxford University Press (OUP)

    Professor Michael G Kiehl

  81. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock

    Article • Intensive Care Medicine, May 1997, Springer Science + Business Media

    Professor Michael G Kiehl

  82. Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedure

    Article • Bone Marrow Transplantation, April 1997, Springer Science + Business Media

    Professor Michael G Kiehl

  83. Volume-Controlled Versus Biphasic Positive Airway Pressure

    Article • Critical Care Medicine, January 1997, Wolters Kluwer Health

    Professor Michael G Kiehl

  84. Mediators in Sepsis and Septic Shock

    Article • January 1997, Springer Science + Business Media

    Professor Michael G Kiehl

  85. A Controlled Trial of Intravenous Immune Globulin for the Prevention of Serious Infections in Adults With Advanced Human Immunodeficiency Virus Infection

    Article • Archives of Internal Medicine, December 1996, American Medical Association (AMA)

    Professor Michael G Kiehl

  86. A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection

    Article • Archives of Internal Medicine, December 1996, American Medical Association (AMA)

    Professor Michael G Kiehl

  87. Characterization of Autoantibodies to Natural Killer Cells in HIV‐Infected Patients

    Article • Scandinavian Journal of Immunology, May 1996, Wiley

    Professor Michael G Kiehl

  88. Volume-controlled versus biphasic positive airway pressure ventilation in leukopenic patients with severe respiratory failure

    Article • Critical Care Medicine, May 1996, Wolters Kluwer Health

    Professor Michael G Kiehl

  89. Bronchiolitis obliterans mit organisierender Pneumonie: Differentialdiagnose der antibiotikarefraktären Pneumonien

    Article • DMW - Deutsche Medizinische Wochenschrift, January 1996, Thieme Publishing Group

    Professor Michael G Kiehl